The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review (Q33311301)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q57080024)
(P304) 411-417
(P407) (Q1860)
(P433) 6
(P478) 36
(P577) Thursday, November 1, 2007
(P921) (Q348260)
(Q187255)
(P1433) (Q15767622)
(P1476) "The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review" (language: en)
(P2093) L E Kristensen
H Bliddal
P Geborek
B Danneskiold-Samsøe
T Saxne
(P2860) (Q41979325)
(Q29619501)
(Q29619499)
(Q34276242)
(Q35579517)
(Q43848301)
(Q30896344)
(Q42759158)
(Q39735046)
(Q24801839)
(Q24801908)
(Q34297134)
(Q36408155)
(Q47643186)
(Q29618913)
(Q52221782)
(Q28295474)
(Q33976382)
(Q34547981)
(Q47262616)
(Q35552265)
(Q34530459)
(Q29616063)
(Q33885648)
(Q39344079)
(Q35630063)
(Q57995927)
(P13046) (Q7318358)
other details
description scientific article

External Links